Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Malignant arrhythmia].

F Solti

    Orvosi Hetilap
    |January 22, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Malignant arrhythmias (MA) are serious heart rhythm disorders, often linked to heart disease but sometimes occurring independently. Advanced diagnostics and therapies are improving MA prognosis, though not all cases are fully treatable.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Fundamental electrophysiological differences between low-dose intracoronary endothelin-1 infusion and myocardial ischemia revealed by multiple monophasic action potential recording.

    Journal of cardiovascular pharmacology·2000
    Same author

    Investigating the dual nature of endothelin-1: ischemia or direct arrhythmogenic effect?

    Life sciences·2000
    Same author

    Intrapericardial infusion of endothelin-1 induces ventricular arrhythmias in dogs.

    Cardiovascular research·1998
    Same author

    Verapamil reduces the arrhythmogenic effect of endothelin.

    Journal of cardiovascular pharmacology·1998
    Same author

    Potential pathophysiologic role of endothelin-1 in canine pericardial fluid.

    Journal of cardiovascular pharmacology·1998
    Same author

    Bradycardia increases the arrhythmogenic effect of endothelin.

    Journal of cardiovascular pharmacology·1998
    Same journal

    [Hungarian primary care: facts, problems and expectations].

    Orvosi hetilap·2026
    Same journal

    [The role of obesity and weight reduction in obstructive sleep apnea].

    Orvosi hetilap·2026
    Same journal

    [Mucinous cystic neoplasm of the liver].

    Orvosi hetilap·2026
    Same journal

    [Towards the elimination of iodine deficiency in Hungary].

    Orvosi hetilap·2026
    Same journal

    [Predictive factors of vocal cord paralysis following thyroid surgery].

    Orvosi hetilap·2026
    Same journal

    [Letter to the editor].

    Orvosi hetilap·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Electrophysiology

    Context:

    • Malignant arrhythmias (MA) affect approximately 5% of patients with arrhythmias.
    • MA are frequently associated with underlying organic heart diseases like coronary heart disease, cardiomyopathy, and valvular heart disease.
    • However, MA can also occur in the absence of structural heart disease, as seen in conditions like Long QT syndrome and Wolff-Parkinson-White syndrome.

    Purpose:

    • To provide an overview of malignant arrhythmias (MA), including their types, diagnostic methods, and therapeutic strategies.
    • To highlight the evolving prognosis of MA with advancements in medical interventions.

    Summary:

    • The most common MA is ventricular tachycardia (VT), which can progress to ventricular fibrillation (VF).
    • Less common forms include primary VF and MA with a predominant bradycardic component.

    Related Experiment Videos

  • Diagnostic tools such as signal-averaged electrocardiography, Holter monitoring, and programmed electrical stimulation are crucial for MA diagnosis.
  • Therapeutic approaches include managing underlying cardiac conditions, antiarrhythmic drugs (effective in ~40% of cases), pacemaker therapy for bradycardic MA, and cardioverter-defibrillator pacemakers for severe VT/VF.
  • Advanced treatments like catheter ablation and surgical interventions are also utilized for specific MA cases.

    • Impact:

    • The prognosis for malignant arrhythmias has significantly improved due to the application of newer therapeutic procedures.
    • Early diagnosis and comprehensive management strategies are key to improving outcomes for patients with MA.